SCHEMBL8636840

SCHEMBL8636840

CC(C)CC(C)N1C(=O)C(N)C(=O)N(c2ccccc2)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 9/20 0.59
ELANE P08246 1/20 0.36
SLC6A2 P23975 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
CCKAR P32238 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAOA P21397 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7041975 0.85 CCKBR (0.42) CCKBRSLC6A2SMN1; SMN2KDM4EGAA
SCHEMBL4424441 0.80 GAA (0.46) SLC6A2KDM4EGAAMAOAALDH1A1
SCHEMBL8547144 0.79 CCKBR (0.60) CCKBRSMN1; SMN2
SCHEMBL8639243 0.76 CCKBR (0.59) CCKBRSLC6A2CCKARKMT2A
SCHEMBL8638271 0.75 CCKBR (1.00) CCKBRCCKAR
SCHEMBL4416338 0.74 GABRP (0.46) CCKBRSLC6A2KDM4EGAAMAOA
SCHEMBL7041976 0.74 CCKBR (0.50) CCKBRELANESLC6A2SMN1; SMN2CCKAR
SCHEMBL8617340 0.72 CCKBR (0.44) CCKBRSMN1; SMN2CCKAR
SCHEMBL8897693 0.72 CCKBR (0.60) CCKBRELANESLC6A2SMN1; SMN2CCKAR
SCHEMBL4415567 0.71 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0558104-B1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO WELLCOME SPA (IT) 1998-07-29 EP disclosed
US-5637697-A ANTAGONIST TO GASTRIN AND(OR) CHLOROCYSTOKININ GLAXO SPA (IT) 1997-06-10 US disclosed
US-5580895-A GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS GLAXO SPA (IT) 1996-12-03 US disclosed
EP-0558104-A1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO S.p.A. (IT) 1993-09-01 EP disclosed